Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

Why did Oracle's stock surge this week? How will Trump's Russia sanctions affect global oil? What caused recent layoffs at xAI? Why is foreign travel to the U.S. declining? How did the Hyundai ICE raid impact investments? What’s driving Tesla’s stock volatility today? Why did the S&P 500 stall after recent gains?

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

benzinga.com/news/fda/25/09/47628375/tempus-ai-gains-fda-clearance-for-updated-pixel-to-boost-accuracy-and-efficiency-in-cardiac-imaging

On Thursday, Tempus AI, Inc. (NASDAQ:TEM) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform.
The update allows the generation of T1 and T2 inline maps, further enhancing the device’s cardiac MR…

This story appeared on benzinga.com, 2025-09-11 17:58:44.